Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

scientific article published on 25 June 2015

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 159 Warning: foreach() argument must be of type array|object, null given in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 161
Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1029233D
P356DOI10.1371/JOURNAL.PONE.0129233
P932PMC publication ID4482141
P698PubMed publication ID26110425
P5875ResearchGate publication ID279303629

P50authorJames BrugarolasQ88683789
Weina ChenQ96231626
P2093author name stringNoelle S Williams
Jin Ye
Harris Naina
Robert Collins
Bray Denard
Andrea Pavia-Jimenez
P2860cites workNeoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup studyQ73042273
Optimal first-line treatment in ovarian cancerQ84987304
ONCOMINE: a cancer microarray database and integrated data-mining platformQ28255103
Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formationQ28587852
Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segmentQ28644805
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysisQ33511922
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinQ33540751
Paclitaxel and anthracycline combination chemotherapy for metastatic breast cancer.Q33686039
Doxorubicin, DNA torsion, and chromatin dynamicsQ34039414
Identification of the molecular basis of doxorubicin-induced cardiotoxicityQ34308627
The role of anthracyclines in small cell lung cancerQ34358063
Renal cell carcinoma: molecular biology and targeted therapyQ34513914
Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testingQ35041892
The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells.Q35116452
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1Q36473616
Epigenetic Silencing of Antiviral Genes Renders Clones of Huh-7 Cells Permissive for Hepatitis C Virus ReplicationQ36506940
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell CarcinomaQ36606040
CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesisQ37469514
Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stressQ38316703
Current combined treatment of high-grade osteosarcomas.Q40405588
Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1cQ43848640
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerQ46491011
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageJQ1659584
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectdoxorubicinQ18936
biomarkerQ864574
P304page(s)e0129233
P577publication date2015-06-25
P1433published inPLOS OneQ564954
P1476titleIdentification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome
P478volume10

Reverse relations

cites work (P2860)
Q64977799Advances in delivery systems for doxorubicin.
Q58786512CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
Q91783111Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients
Q36503782Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
Q47194903Regulation of cAMP Responsive Element Binding Protein 3-Like 1 (Creb3l1) Expression by Orphan Nuclear Receptor Nr4a1.
Q36845828Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells
Q90077722Uptake of HDL-cholesterol contributes to lipid accumulation in clear cell renal cell carcinoma

Search more.